2022-02-28 07:01:08 +00:00
{
"CVE_data_meta" : {
"ASSIGNER" : "cve@mitre.org" ,
2022-10-06 17:39:23 +00:00
"ID" : "CVE-2022-26235" ,
"STATE" : "PUBLIC"
2022-02-28 07:01:08 +00:00
} ,
2022-10-06 17:39:23 +00:00
"affects" : {
"vendor" : {
"vendor_data" : [
{
"product" : {
"product_data" : [
{
"product_name" : "n/a" ,
"version" : {
"version_data" : [
{
"version_value" : "n/a"
}
]
}
}
]
} ,
"vendor_name" : "n/a"
}
]
}
} ,
"data_format" : "MITRE" ,
"data_type" : "CVE" ,
"data_version" : "4.0" ,
2022-02-28 07:01:08 +00:00
"description" : {
"description_data" : [
{
"lang" : "eng" ,
2022-10-06 17:39:23 +00:00
"value" : "A vulnerability was discovered in the Remisol Advance v2.0.12.1 and below for the Normand Message Server. On installation, the permissions set by Remisol Advance allow non-privileged users to overwrite and/or manipulate executables and libraries that run as the elevated SYSTEM user on Windows."
}
]
} ,
"problemtype" : {
"problemtype_data" : [
{
"description" : [
{
"lang" : "eng" ,
"value" : "n/a"
}
]
}
]
} ,
"references" : {
"reference_data" : [
{
"url" : "https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance" ,
"refsource" : "MISC" ,
"name" : "https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance"
} ,
{
"refsource" : "MISC" ,
"name" : "https://pastebin.com/amgw9pE7" ,
"url" : "https://pastebin.com/amgw9pE7"
2022-02-28 07:01:08 +00:00
}
]
}
}